AU4459196A - Sustained-release preparation and use - Google Patents

Sustained-release preparation and use

Info

Publication number
AU4459196A
AU4459196A AU44591/96A AU4459196A AU4459196A AU 4459196 A AU4459196 A AU 4459196A AU 44591/96 A AU44591/96 A AU 44591/96A AU 4459196 A AU4459196 A AU 4459196A AU 4459196 A AU4459196 A AU 4459196A
Authority
AU
Australia
Prior art keywords
sustained
release preparation
release
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44591/96A
Inventor
Yasutaka Igari
Shigeru Kamei
Akira Saikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU4459196A publication Critical patent/AU4459196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
AU44591/96A 1995-01-23 1996-01-19 Sustained-release preparation and use Abandoned AU4459196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-8224 1995-01-23
JP822495 1995-01-23
PCT/JP1996/000090 WO1996022786A1 (en) 1995-01-23 1996-01-19 Sustained-release preparation and use

Publications (1)

Publication Number Publication Date
AU4459196A true AU4459196A (en) 1996-08-14

Family

ID=11687213

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44591/96A Abandoned AU4459196A (en) 1995-01-23 1996-01-19 Sustained-release preparation and use

Country Status (2)

Country Link
AU (1) AU4459196A (en)
WO (1) WO1996022786A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853740A (en) * 1996-08-07 1998-12-29 Abbott Laboratories Delivery system for pharmaceutical agents encapsulated with oils
ES2205481T3 (en) * 1997-04-17 2004-05-01 Amgen Inc. BIODEGRADABLE MICROPARTICLES FOR SUSTAINED RELEASE OF THERAPEUTIC PHARMACOS.
CA2316273A1 (en) 1998-01-16 1999-07-22 Takeda Chemical Industries, Ltd. Sustained-release composition, method of its production and use thereof
US6350464B1 (en) * 1999-01-11 2002-02-26 Guilford Pharmaceuticals, Inc. Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
US6204308B1 (en) 1999-03-01 2001-03-20 Novartis Ag Organic compounds
RU2002103718A (en) 1999-07-15 2003-10-10 Такеда Кемикал Индастриз, Лтд. (JP) COMPOSITIONS OF LONG-TERM ACTION, WAYS OF THEIR OBTAINING AND APPLICATION
DE10137174A1 (en) * 2001-07-31 2003-02-13 Zentaris Ag Method of modifying T-cell populations, e.g. for treatment of HIV infection or cancer, comprises administrating luteinizing hormone releasing hormone antagonist at controlled dose insufficient to cause chemical castration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.

Also Published As

Publication number Publication date
WO1996022786A1 (en) 1996-08-01

Similar Documents

Publication Publication Date Title
IL118825A0 (en) 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use
IL119864A0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
GB2298422B (en) Compounds and their use
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
AU4877896A (en) Preparation
AU4900096A (en) Task chair
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
AU4266596A (en) Composition and use
PL321686A1 (en) Trensdermal preparation
AU7095296A (en) Phosphorylamides, their preparation and use
NZ300198A (en) Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines
AU4224096A (en) Use of phenylcyclohexylcarboxamides
IL116710A0 (en) Substituted 2-phenylpyridines their preparation and use
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
IL118295A0 (en) 3-(2- trialkylsilyloxy) ethyl-7-ethyl-1H- indoles and their preparation
IL116712A0 (en) Substituted 2-phenylpyridines their preparation and use
AU2698795A (en) Human chemokine beta-12
AU7301596A (en) Chair
AU4459196A (en) Sustained-release preparation and use
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
IL116711A0 (en) Substituted 2-phenylpyridines their preparation and use
IL116658A0 (en) Peptides their preparation and use